Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, April 5, 2016

Cost-effectiveness of endovascular thrombectomy in patients with acute ischemic strokeROKE

This seems extremely odd that cost is more important that the results of the intervention. 'It costs this much, but the patient died'.
https://cme.neurology.org/attendee/view_program.jsp?programCode=21063PAWgCjx

Neurology: Volume 86, Number 11, March 15, 2016 Exam #2

About this course

  • Released: 3/15/2016
  • Expires: 3/15/2019


COST-EFFECTIVENESS OF ENDOVASCULAR THROMBECTOMY IN PATIENTS WITH ACUTE ISCHEMIC STROKE

LEARNING OBJECTIVES:

Upon completion of the article by Aronsson et al, the participant should be able to:
  • Identify under which clinical trial results endovascular thrombectomy would result in cost-savings or cost-effectiveness
  • State the probability at which endovascular thrombectomy would be considered cost-saving (improved outcomes at lower costs) for acute ischemic stroke (AIS)
  • Identify clinical parameters that would significantly affect the cost-effectiveness of endovascular thrombectomy in AIS


CORE COMPETENCIES:

The article by Aronsson et al covers the following core competency:
  • Medical Knowledge


AUTHOR DISCLOSURES:

Refer to listing above the references in each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

AMA CREDIT DESIGNATION STATEMENT

The American Academy of Neurology Institute designates this journal-based-CME activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURES

Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as Editor-in-Chief of Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)